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Antioxidant vitamins and glucose-6-phosphate
dehydrogenase deficiency in full-term neonates
AntioxidativeVitamineundGlucose-6-Phosphat-Dehydrogenase-Mangel
bei ausgereiften Neugeborenen
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Zusammenfassung
Ziel der Studie: Der Mechanismus, durch den ein Mangel an Glucose-
6-Phosphat-Dehydrogenase(G6PD)beiNeugeboreneneineHyperbiliru-
binämie erzeugt, ist noch nicht vollständig erforscht. Allerdings schafft
dergenetischeDefekteinesG6PD-MangelseineVeranlagungderroten
Blutzellen zu oxidativem Stress. Das Ziel der vorliegenden Arbeit war
es,dieBeziehungzwischendenKonzentrationenantioxidativerVitamine
(VitaminEundC)imPlasmaundderEntstehungderHyperbilirubinämie
bei ausgereiften Neugeborenen mit G6PD-Mangel festzustellen.
Methoden: 196 Neugeborene von gesunden Müttern wurden in diese
Studie eingeschlossen. 12 dieser Neugeborenen hatten einen G6PD-
Mangel. Neben den demografischen Daten wurden am 1. Tag nach der
GeburtdieKonzentrationenvonGesamtbilirubin,Hämoglobin,Hämato-
krit sowie Vitamin E und C bestimmt.
Ergebnisse: Neugeborene mit einem G6PD-Mangel (n=7), die keine
Hyperbilirubinämie entwickelt haben (mittlerer Serum-Bilirubin-Spiegel
70,8±23 µmol/l, median 71,8 µmol/l), und Neugeborene mit einem
G6PD-Mangel (n=4), die am 1. Lebenstag eine Hyperbilirubinämie ent-
wickelt haben (mittlerer Serum-Bilirubin-Spiegel 226,7±79 µmol/l,
median 233,4 µmol/l), waren in Bezug auf Geburtsgewicht und
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Original Article OPEN ACCESSSchwangerschaftsalter vergleichbar. Die zweite Gruppe wies allerdings
niedrigereKonzentrationenvonHämoglobin,HämatokritsowieVitamin
CundEauf.AberkeinesdieserMessergebnissezeigteeinesignifikante
Differenz.
Schlussfolgerung:DieErgebnissedervorliegendenStudiezeigen,dass
HyperbilirubinämienichtalleindurchHämolysealsFolgeeinesunzurei-
chenden Antioxidationssystem bei Neugeborenen mit G6PD-Mangel
verursacht wird.
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Introduction
Glucose-6-phosphate dehydrogenase (G6PD) is the first
enzyme in the pentose phosphate pathway in red blood
cells [1]. The main physiologic role of this pathway is to
generatethereducednicotinamideadeninedinucleotide
phosphate (NADPH) necessary for protection of the cells
againstoxidativestress[2].NADPHmaintainsglutathione
in the reduced state when erythrocytes are subjected to
an oxidative stress [3]. Low activities of G6PD render red
blood cells susceptible to hemolysis under certain condi-
tions such as ingestion of fava beans, certain drugs, and
severe infections [1], [4].
G6PD deficiency is one of the most common human en-
zymedeficiencies,affectingmorethan400millionpeople
worldwide [5], [6]. Common clinical manifestations of
G6PD-deficientsubjectsareneonataljaundiceandacute
hemolytic anemia [7]. Most people with this disorder are
malesincetheinheriteddeficiencyisanX-linkedenzymat-
ic defect [7], [8]. G6PD deficiency is the most significant
factor that contributes to severe neonatal hyperbilirubin-
aemia and kernicterus [9], [10]. Distribution of the defi-
ciency varies among different populations reflecting
geographicandethnicvariations[6]withhighprevalence
in the Middle East [4].
Antioxidant vitamins (E and C) are considered one of the
defense systems against reactive oxygen species [11].
Vitamin E is a potent antioxidant that effectively protects
biological membranes against oxidative injury [12]. Sup-
plementation of vitamin E to preterm infants with hyper-
bilirubinemia results in significant reduction in plasma
bilirubinlevelwhichissuggestedtobecausedbyareduc-
tioninredcellhemolysis[13].Previously,wehavereport-
ed the association between plasma antioxidant vitamins
(E and C) and hyperbilirubinemia in full-term neonates
[14]. We attributed the significant hyperbilirubinemia to
increasedoxidativestressduetolowlevelsofantioxidant
vitamins and in turn erythrocytes haemolysis.
A limited number of studies on the role and status of
vitamin E and C in neonate with G6PD deficiency with or
without hyperbilirubinemia can be found in literature.
Therefore,thisstudywasundertakentoassessthestatus
of plasma vitamin E and C and to establish the relation-
ship between antioxidant vitamin levels and the develop-
ment of hyperbilirubinemia in full-term neonates with
deficient G6PD.
Materials and methods
Study protocol
This study was approved by The Review Committee for
Research on Human at Jordan University of Science and
Technology(JUST).Thepopulationofthisstudyconsisted
of live birth neonates that consecutively delivered at
PrincessRahmaHospital,Irbid-Jordan,fortheperiodfrom
March to July 2004. Both females and males were in-
cluded in this study. In all cases gender, birth weight and
gestational age were recorded.
Laboratory analyses
All laboratory analyses were conducted on venous blood
obtained into heparinized glass tubes from all infants in-
cluded in this study on the day of birth as stated previ-
ously [14]. In brief, plasma total bilirubin level was
measured using bilirubin analyzer BA III (Tokyo, Japan).
Hemoglobin and hematocrit were measured using auto-
matedbloodcounter(Micros60OT,Montpellier,France).
For detection of G6PD deficiency, a methemoglobin re-
duction test was used [15]. Plasma vitamin C level was
measured by calorimetric method [16]. Plasma vitamin
Elevelwasmeasuredbyhighperformanceliquidchroma-
tography (HPLC) [17].
Statistical analysis
Data was evaluated by Minitab Statistical Software re-
lease 14. Mann-Whitney test was used to compare the
significanceofmediandifferencebetweenthetwogroups.
P values <0.05 were considered statistically significant.
Results
During the study period, 196 neonates were studied, out
of which 12 (6.1%) were deficient in G6PD enzyme: 11
full-term neonates (10 male and 1 female) and one pre-
maturemale.Gestationalageandbirthweightofthetwo
groups showed no significant differences.
The hemoglobin and hematocrit were lower in neonates
with hyperbilirubinemia than in neonates without hyper-
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bilirubinemia, but the differences were not statistically
significant (Table 1).
Similar results were found for plasma vitamin E and C
levels. They were lower in neonates with hyperbiliru-
binemia than in neonates who did not develop hyperbi-
lirubinemia, but the differences were not statistically
significant (Table 2).
Discussion
High bilirubin load due to erythrocyte hemolysis plays an
important role in neonatal hyperbilirubinemia. The rea-
sons are higher erythrocyte turnover, shorter life span
and diminished capacity of neonatal erythrocytes to deal
with oxidative stress as a result of decreased antioxidant
defence system particularly in the preterm infants [18],
[19], [20], [21]. Erythrocytes are prone to oxidative reac-
tionsduetorelativelyhighoxygenation,hemoglobin,and
plasma membrane rich in a polyunsaturated fatty acids
[22]. The magnitude of hemolysis has been shown to be
directlyproportionaltotheamountoffreeradicalspresent
thatcanbeinhibitedbyantioxidantsubstances[23],[24].
The mechanism by which G6PD deficiency causes
neonatalhyperbilirubinemiaisnotcompletelyunderstood
[25].Redbloodhemolysismaybeobserved[25]orfound
to be associated [26] with jaundice in neonates with
G6PD deficiency. The genetic disorder G6PD deficiency
predisposesredbloodcellstooxidativestressandhence,
dependingonthebalanceofoxidantspeciesandantioxi-
dants,thismayleadtoredcellhemolysisandhyperbiliru-
binemia [27]. Ojo et al. [28] observed that full-term
neonates with highest plasma bilirubin levels had lowest
plasma vitamin E values, especially in G6PD-deficient
erythrocytes. Vitamin E is known to be a cellular antioxi-
dant [22] that prevents membrane damage by inhibiting
lipid peroxidation [11].
Vitamin C is a water soluble antioxidant and has also
been found to suppress erythrocyte hemolysis induced
by water-soluble radical initiator [29]. The synergistic ef-
fect between vitamin E and C in inhibition of lipid peroxi-
dation has been reported previously [30].
In our study, neonates of both groups had similar gesta-
tional weights and age. Despite these similarities,
hemoglobin, hematocrit as well as plasma antioxidant
vitamins E and C levels were lower in neonates who de-
veloped hyperbilirubinemia. This finding explains the
protective action of these vitamins against hemolytic an-
emia in G6PD-deficient neonates who developed hyper-
bilirubinemia. This is in agreement with Bizzarro et al.
[31] who reported that hemolysis may be observed in
neonateswithG6PDdeficiencyandjaundicethatexacer-
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dicate that red blood cell hemolysis due to the toxic ef-
fectsofoxidantsandtheinadequateantioxidantssystem
are not the only contributing factors for development of
hyperbilirubinemia in G6PD-deficient neonates. This cor-
responds with Jalloh et al. [33] and Kaplan et al. [34],
who found that hemolysis is not the main determinant of
neonatal jaundice in G6PD-deficient babies. Hyperbiliru-
binemia in G6PD-deficient infants is also likely to occur
secondarytoinabilityofthelivertoadequatelyconjugate
and clear bilirubin as a result of a mutation of uridine di-
phosphoglucuronate glucuronosyltransferase-1 gene
promoter leading to hyperbilirubinemia [25], [35]. Weng
et al. [36] showed that G6PD-deficient neonates were at
increased risk for hyperbilirubinemia and that G6PD
activity of male newborns that developed hyperbiliru-
binemiawassignificantlylowerthantheneonateswithout
hyperbilirubinemia. This points out the importance of
knowing the degree of G6PD activity since this enzyme
isresponsibleforthegenerationofNADPH,animportant
factor in the generation of reduced gluthathione, which
is an endogenous antioxidant affecting the balance
between oxidants and antioxidants.
Conclusion
In the present study, it was shown that the development
ofhyperbilirubinemiainG6PD-deficientneonatescannot
be attributed only to hemolysis of red blood cells as a
result of inadequate antioxidants system.
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